The FDA decision on Paradigm Medical Industries, Inc. (OTC: PDMI) lead device candidate ParaMax for Glaucoma early detection is expecting anytime soon. ParaMax device for early Glaucoma detection is awaiting FDA approval. Paradigm’s (OTC: PDMI) has recently announced that his Italian partner CSO (Costruzione Strumenti Oftalmici) has completed and submitted all necessary documents to the [...]




